Chen Lu1, Xiaohui Wang1, Tuanzhu Ha2, Yuanping Hu1, Li Liu3, Xia Zhang1, Honghui Yu4, Jonathan Miao1, Race Kao2, John Kalbfleisch5, David Williams2, Chuanfu Li6. 1. Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States. 2. Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States; Center for Inflammation, Infectious Disease and Immunity, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States. 3. Department of Geriatrics, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China. 4. Department of Anesthesiology, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China. 5. Department of Biometry and Medical Computing, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States; Center for Inflammation, Infectious Disease and Immunity, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States. 6. Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States; Center for Inflammation, Infectious Disease and Immunity, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614, United States. Electronic address: Li@etsu.edu.
Abstract
OBJECTIVE: Activation of PI3K/Akt signaling protects the myocardium from ischemia/reperfusion injury. MicroRNAs have been demonstrated to play an important role in the regulation of gene expression at the post-transcriptional level. In this study, we examined whether miR-130a will attenuate cardiac dysfunction and remodeling after myocardial infarction (MI) via PI3K/Akt dependent mechanism. APPROACHES AND RESULTS: To determine the role of miR-130a in the proliferation and migration of endothelial cells, HUVECs were transfected with miR-130a mimics before the cells were subjected to scratch-induced wound injury. Transfection of miR-130a mimics stimulated the migration of endothelial cells into the wound area and increased phospho-Akt levels. To examine the effect of miR-130a on cardiac dysfunction and remodeling after MI, Lentivirus expressing miR-130a (LmiR-130a) was delivered into mouse hearts seven days before the mice were subjected to MI. Cardiac function was assessed by echocardiography before and for up to 21 days after MI. Ejection fraction (EF%) and fractional shortening (FS%) in the LmiR-130a transfected MI hearts were significantly greater than in LmiR-control and untransfected control MI groups. LmiR-130a transfection increased capillary number and VEGF expression, and decreased collagen deposition in the infarcted myocardium. Importantly, LmiR-130a transfection significantly suppressed PTEN expression and increased the levels of phosphorylated Akt in the myocardium. However, treatment of LmiR-130a-transfected mice with LY294002, a PI3K inhibitor, completely abolished miR-130a-induced attenuation of cardiac dysfunction after MI. CONCLUSIONS: miR-130a plays a critical role in attenuation of cardiac dysfunction and remodeling after MI. The mechanisms involve activation of PI3K/Akt signaling via suppression of PTEN expression.
OBJECTIVE: Activation of PI3K/Akt signaling protects the myocardium from ischemia/reperfusion injury. MicroRNAs have been demonstrated to play an important role in the regulation of gene expression at the post-transcriptional level. In this study, we examined whether miR-130a will attenuate cardiac dysfunction and remodeling after myocardial infarction (MI) via PI3K/Akt dependent mechanism. APPROACHES AND RESULTS: To determine the role of miR-130a in the proliferation and migration of endothelial cells, HUVECs were transfected with miR-130a mimics before the cells were subjected to scratch-induced wound injury. Transfection of miR-130a mimics stimulated the migration of endothelial cells into the wound area and increased phospho-Akt levels. To examine the effect of miR-130a on cardiac dysfunction and remodeling after MI, Lentivirus expressing miR-130a (LmiR-130a) was delivered into mouse hearts seven days before the mice were subjected to MI. Cardiac function was assessed by echocardiography before and for up to 21 days after MI. Ejection fraction (EF%) and fractional shortening (FS%) in the LmiR-130a transfected MI hearts were significantly greater than in LmiR-control and untransfected control MI groups. LmiR-130a transfection increased capillary number and VEGF expression, and decreased collagen deposition in the infarcted myocardium. Importantly, LmiR-130a transfection significantly suppressed PTEN expression and increased the levels of phosphorylated Akt in the myocardium. However, treatment of LmiR-130a-transfected mice with LY294002, a PI3K inhibitor, completely abolished miR-130a-induced attenuation of cardiac dysfunction after MI. CONCLUSIONS: miR-130a plays a critical role in attenuation of cardiac dysfunction and remodeling after MI. The mechanisms involve activation of PI3K/Akt signaling via suppression of PTEN expression.
Authors: Antonio Abbate; Celina Morales; Maria De Falco; Valentina Fedele; Giuseppe G L Biondi Zoccai; Daniele Santini; Jimena Palleiro; Fortunata Vasaturo; Susanna Scarpa; Giovanna Liuzzo; Anna Severino; Feliciano Baldi; Filippo Crea; Luigi M Biasucci; George W Vetrovec; Ricardo J Gelpi; Alfonso Baldi Journal: Int J Cardiol Date: 2006-11-15 Impact factor: 4.164
Authors: Kim Rhoads; Gemma Arderiu; Aubri Charboneau; Scott L Hansen; William Hoffman; Nancy Boudreau Journal: Lymphat Res Biol Date: 2005 Impact factor: 2.589
Authors: E Hochhauser; Y Cheporko; N Yasovich; L Pinchas; D Offen; Y Barhum; H Pannet; A Tobar; B A Vidne; E Birk Journal: Cell Biochem Biophys Date: 2007 Impact factor: 2.194
Authors: Tuanzhu Ha; Fang Hua; Xiang Liu; Jing Ma; Julie R McMullen; Tetsuo Shioi; Seigo Izumo; Jim Kelley; Xiag Gao; William Browder; David L Williams; Race L Kao; Chuanfu Li Journal: Cardiovasc Res Date: 2008-02-11 Impact factor: 10.787
Authors: Philippe Chouvarine; Ekaterina Legchenko; Jonas Geldner; Christian Riehle; Georg Hansmann Journal: J Mol Med (Berl) Date: 2019-07-23 Impact factor: 4.599
Authors: He Ma; Xiaohui Wang; Tuanzhu Ha; Ming Gao; Li Liu; Ruitao Wang; Kaijiang Yu; John H Kalbfleisch; Race L Kao; David L Williams; Chuanfu Li Journal: J Infect Dis Date: 2016-09-28 Impact factor: 5.226